Raghuvir Synthetics Intrinsic Value
Raghuvir Synthetics (RAGHUSYN) median intrinsic value is ₹192.00 from 3 valuation models (range ₹85–₹250), vs current price ₹99.80 — +92.4% upside (Trading Below Calculated Value), margin of safety 48.0%. Read RAGHUSYN ex-dividend dates for the complete payout history and dividend yield track record.
RAGHUSYN Valuation Methods Summary — DCF, Graham Number & P/E
Raghuvir Synthetics intrinsic value across 3 models vs current price ₹99.80 — upside/downside and value range per method. Analyse RAGHUSYN FII DII holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹85.00 | ₹76.50 - ₹93.50 | -14.8% | Book Value/Share: ₹85.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹192.00 | ₹172.80 - ₹211.20 | +92.4% | Revenue/Share: ₹240.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹249.50 | ₹199.60 - ₹299.40 | +150.0% | CF Growth: 15.0%, Discount: 15% |
RAGHUSYN Intrinsic Value vs Market Price — All Valuation Models
Raghuvir Synthetics fair value range ₹85–₹250 vs current market price ₹99.80 across 3 valuation models. For current market price and key ratios, visit RAGHUSYN share price screener.
RAGHUSYN Intrinsic Value Analysis — Undervalued or Overvalued?
Raghuvir Synthetics median intrinsic value ₹192.00, current price ₹99.80 — Trading Below Calculated Value by 92.4%, margin of safety 48.0%.
What is the intrinsic value of RAGHUSYN?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Raghuvir Synthetics (RAGHUSYN) is ₹192.00 (median value). With the current market price of ₹99.80, this represents a +92.4% variance from our estimated fair value.
The valuation range spans from ₹85.00 to ₹249.50, indicating ₹85.00 - ₹249.50.
Is RAGHUSYN undervalued or overvalued?
Based on our multi-method analysis, Raghuvir Synthetics (RAGHUSYN) appears to be trading below calculated value by approximately 92.4%.
RAGHUSYN Financial Health — Key Ratios vs Industry Benchmarks
Raghuvir Synthetics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.65 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -47.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RAGHUSYN Cash Flow Quality — Operating & Free Cash Flow
Raghuvir Synthetics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹24 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹16 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹14 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹7 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹5 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |